The World Health Organization on Friday approved Bavarian Nordic’s MVA-BN vaccine as the first shot against vapox. The World Health Organization said on Friday it had granted its first authorization for use of a vaccine against vapox in adults, calling it an important step toward fighting the disease in Africa and beyond. The pre-qualification of the vaccine by Bavarian Nordic A/S means that donors such as the GAVI vaccine alliance and UNICEF can buy it. But supplies are limited because there is only one manufacturer.
Bavarian Nordic (BAVA.CO) Vaccines
The World Health Organization said on Friday it had approved the Bavarian Nordic (BAVA.CO) vaccine as the first shot against the virus. The approval, known as pre-qualification, is an official listing of medicines used as a benchmark for purchases by developing countries. “This first prequalification of a vaccine against the virus is an important step in our fight against the disease, both in the context of the current outbreaks in Africa and in the future,” WHO Director-General Dr. Tedros Adhanom Ghebreyesus said."text-align: justify;">Read also:Why do people commit suicide? You can understand the condition of the heart of your loved one from these signs
Vaccine will be given in these countries including Africa
WHO Director-General Tedros Adhanom Ghebreyesus said: “This first pre-qualification of a vaccine against m-pox is a crucial step in our fight against the disease in Africa, both against current outbreaks and in the future.” The head of the UN health agency called for an urgent scale-up of procurement, donations and rollout, alongside other response measures, to ensure vaccines are delivered where they are needed most.
Read this also: Motion Sickness: Do you also suffer from motion sickness? Then take note of these simple tips, you will get relief immediately
2 doses of the vaccine will be given to people of this age
Under the WHO authorization, the vaccine can be given to people aged 18 years or older in a two-dose regimen. The approval states that although the vaccine is not currently licensed for people under 18 years of age, it can be used in infants, children and adolescents in outbreak areas where the benefits of vaccination outweigh the potential risks.
Disclaimer: Some of the information given in the news is based on media reports. You must consult the concerned expert before implementing any suggestion.